Jane Street Group, LLC Cassava Sciences Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 310,600 shares of SAVA stock, worth $8.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

310,600

Previous 120,148 158.51%

Holding current value

$8.09 Million

Previous $1.48 Million 516.32%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $413,567 - $1.52 Million	-43,215 Reduced 35.97%	76,933 $2.26 Million
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $293,448 - $620,399	23,761 Added 24.65%	120,148 $1.48 Million
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $5.12 Million - $7.34 Million	-277,819 Reduced 74.24%	96,387 $1.96 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $4.56 Million - $10.9 Million	360,686 Added 2667.8%	374,206 $8.42 Million
Q3 2023 Nov 14, 2023	SELL	$16.64 - $25.32 $507,020 - $771,500	-30,470 Reduced 69.27%	13,520 $224,000
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $484,350 - $625,459	22,434 Added 104.07%	43,990 $1.08 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $298,458 - $463,589	12,722 Added 144.01%	21,556 $519,000
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $392,289 - $622,700	-14,101 Reduced 61.48%	8,834 $260,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $126,263 - $394,795	7,732 Added 50.86%	22,935 $959,000
Q2 2022 Aug 16, 2022	BUY	$17.22 - $38.47 $33,957 - $75,862	1,972 Added 14.9%	15,203 $428,000
Q1 2022 May 17, 2022	SELL	$32.6 - $53.05 $3.12 Million - $5.08 Million	-95,812 Reduced 87.87%	13,231 $491,000
Q4 2021 Feb 15, 2022	SELL	$36.77 - $90.91 $1.46 Million - $3.6 Million	-39,607 Reduced 26.64%	109,043 $4.76 Million
Q3 2021 Nov 16, 2021	SELL	$41.79 - $135.3 $1.09 Million - $3.54 Million	-26,181 Reduced 14.98%	148,650 $9.23 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $3.28 Million - $9.16 Million	102,071 Added 140.28%	174,831 $14.9 Million
Q1 2021 May 18, 2021	BUY	$7.09 - $87.95 $116,857 - $1.45 Million	16,482 Added 29.29%	72,760 $3.27 Million
Q4 2020 Feb 17, 2021	BUY	$6.79 - $12.25 $288,887 - $521,188	42,546 Added 309.83%	56,278 $384,000
Q3 2020 Nov 17, 2020	SELL	$2.86 - $11.51 $232,294 - $934,865	-81,222 Reduced 85.54%	13,732 $158,000
Q2 2020 Aug 17, 2020	BUY	$2.04 - $9.64 $144,778 - $684,150	70,970 Added 295.91%	94,954 $292,000
Q1 2020 May 15, 2020	BUY	$3.26 - $9.65 $21,890 - $64,799	6,715 Added 38.88%	23,984 $99,000
Q4 2019 Feb 14, 2020	BUY	$1.1 - $6.12 $3,606 - $20,067	3,279 Added 23.44%	17,269 $90,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.45 $14,549 - $20,285	13,990 New	13,990 $17,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.04B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Cassava Sciences Inc Transaction History